Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-08-30
2011-08-30
Anderson, James (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S637000, C514S821000
Reexamination Certificate
active
08008352
ABSTRACT:
Pentafluorosulfanylbenzoylguanidines, of the formula I and IIin which R1 to R4 have the meanings stated in the claims, are suitable as antiarrhythmic medicaments with a cardioprotective component for the prophylaxis of infarction and treatment of infarction and for the treatment of angina pectoris. They also inhibit preventively the pathophysiological processes associated with the development of ischemia-induced damage, especially in the triggering of ischemia-induced cardiac arrhythmias.
REFERENCES:
patent: 5571842 (1996-11-01), Kleemann
patent: 5747539 (1998-05-01), Dorsch et al.
patent: 5849928 (1998-12-01), Hawkins
patent: 5866610 (1999-02-01), Lang
patent: 6114393 (2000-09-01), Lang
patent: 6156800 (2000-12-01), Weichert
patent: 6348476 (2002-02-01), Scholz et al.
patent: 6420430 (2002-07-01), Linz
patent: 6462024 (2002-10-01), Lang
patent: 19711953 (1997-09-01), None
patent: 2746393 (1997-09-01), None
The “NIH Heart Disease & Stroke Research: Fact Sheet” (American Heart Association, 2004).
“Cardiovascular Disease: Treatment for Stroke”, Stanford Hospital & Clinics, 2003.
“Acute Congestive Heart Failure”, Thomas N. Levin, Postgraduate Medicine, vol. 101, No. 1, 1997).
“UCLA Cardiac Arrhythmia Center”, www.arrhythmia.ucla.edu, 2010.
Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010.
Konig W. et al., Perchloric Acid in Peptide Chemistry, Peptides, (1990), Proc. European Peptide Symp., 21st (1991), pp. 143-145.
Levin, T. H., et. al., Acute Congestive Heart Failure, Postgraduate Medicine, vol. 101, No. 1, (1997).
March J., Aliphatic Nucleophilic Substitution, Advanced Organic Chemistry, 3rd Edition, John Wiley & Sons, 1985, p. 350.
Sheppard William A., Arylsulfur Pentafluorides, Journal of the American Chemical Society; vol. 84; No. 16; (Aug. 20, 1962); pp. 3064-3072.
Staab Angew, Syntheses Using Heterocyclic Amides (Azolides) [*], Chem. Int. Ed. Engl, 1, 351-367.
Cardiovascular Disease: Treatment for Stroke, Stanford Hospital & Clinics (2003).
NIH Heart Disease & Stroke Research: Fact Sheet, American Heart Association (2004).
Oncology, Cecil Textbook of Medicine 20th Edition (1987) pp. 1004-1010.
Anderson James
Polansky Gregg
Sanofi-Aventis Deutschland GmbH
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Pentafluorosulfanylbenzoylguanidines, processes for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pentafluorosulfanylbenzoylguanidines, processes for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pentafluorosulfanylbenzoylguanidines, processes for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2628802